KKR Gets Go-Ahead for $2.38B Capsugel Deal

Private equity firm Kohlberg Kravis Roberts & Co. has been granted approval by the European Union to purchase the Capsugel unit of Pfizer, Reuters reported. KKR will pay nearly $2.38 billion for the unit, which makes hard capsules for pharmaceuticals.

DealsNorth AmericaUSBriefs